🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Re-Engineered Discharge for Diabetes Care Transitions

RecruitingNAAges 18 Years - anyAllUniversity of Massachusetts, Worcester
NCT06869057 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * adult aged 18 years or older * diagnosed with type 2 diabetes * hospitalized at Univ of Massachusetts-affiliated hospital * endorsed at least 1 unmet social need via screening survey Exclusion Criteria: * pregnancy * discharge to short or long-term nursing facility or hospital * medical contraindication * cognitive impairment * unable to provide informed consent
💊

What it tests

  • REDDCAT2 Post-Discharge Navigation
  • Treatment as Usual (TAU)
📍

Where

1 site
UMASS Memorial Healthcare System
Worcester, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy